Behavioral Sleep Medicine,
Journal Year:
2021,
Volume and Issue:
20(4), P. 393 - 409
Published: May 28, 2021
Objective:
Emerging
evidence
links
maternal
and
infant
sleep
problems
to
impairments
in
the
mother-to-infant
bond,
but
independence
directionality
of
these
associations
remain
unclear.
The
present
study
characterized
concurrent
prospective
effects
disturbances
poor
on
mother-infant
relationship.
As
common
sequalae
problematic
sleep,
nocturnal
cognitive
hyperarousal
daytime
sleepiness
were
investigated
as
facilitating
mechanisms.Participants:
Sixty-seven
pregnant
women
enrolled
a
sleep.Methods:
Sociodemographic
information
clinical
symptoms
measured
prenatally
then
weekly
across
first
two
postpartum
months.
Women
reported
insomnia
symptoms,
duration,
snoring,
sleepiness,
arousal
(broadly
focused
perinatal-specific),
perseverative
thinking,
depression,
colic,
quality,
relationship
quality.
Mixed
models
conducted
test
hypotheses.Results:
Prenatal
snoring
weak
maternal-fetal
attachment
augured
poorer
bonding.
Poor
was
associated
with
increased
odds
for
short
sleep.
Impairments
bond
linked
insomnia,
perinatal-focused
rumination,
Postnatal
predicted
future
decreases
partially
mediated
this
association.Conclusions:
Both
bonding,
independent
depression
colic.
Perseverative
thinking
at
night,
particularly
infant-related
concerns,
impaired
rejection
anger,
infant-focused
anxiety.
Improving
reducing
arousal,
may
improve
maternal-to-infant
bond.
Faculty Reviews,
Journal Year:
2022,
Volume and Issue:
11
Published: Feb. 1, 2022
Cognitive
behavioral
therapy
for
insomnia
(CBT-I)
has
been
shown
to
be
efficacious
and
now
is
considered
the
first-line
treatment
both
uncomplicated
that
occurs
comorbidly
with
other
chronic
disorders
(comorbid
insomnia).
The
purposes
of
this
review
are
provide
a
comprehensive
summary
efficacy
data
(for
example,
overall
by
clinical
demographic
considerations
CBT-I
formulation)
discuss
future
what
next
steps
should
taken
in
terms
research,
dissemination,
implementation,
practice).
SLEEP,
Journal Year:
2022,
Volume and Issue:
45(12)
Published: Oct. 15, 2022
Insomnia
is
associated
with
elevated
levels
of
suicidal
thoughts
and
behaviors.
Emerging
evidence
suggests
that
cognitive-behavioral
therapy
for
insomnia
(CBTI)
may
reduce
ideation
(SI).
However,
the
role
digital
therapeutics
in
both
alleviation
prevention
SI
remains
unclear,
treatment
mechanisms
facilitating
reductions
have
not
been
clearly
identified.A
total
658
adults
Diagnostic
Statistical
Manual
Mental
Disorders,
5th
Edition
disorder
enrolled
a
single-site
randomized
controlled
trial
evaluating
efficacy
CBTI
relative
to
attention
control.
Outcomes
were
measured
at
pretreatment,
posttreatment,
1-year
follow-up.Before
treatment,
126
patients
endorsed
(19.1%
prevalence).
Among
those
baseline
SI,
reported
lower
rates
posttreatment
(30.0%
vs
54.5%,
p
=
.005)
follow-up
(29.6%
46.8%,
.042)
PRODCLIN
analysis
estimated
half
suicidolytic
effects
mediated
through
remission.
without
did
directly
prevent
new
onset
SI.
remitters
new-onset
non-remitters
(1.5%
6.5%,
.009).
Mediation
supported
significant
indirect
effect
wherein
increased
likelihood
remission,
which
was
(αβ
-3.20,
95%
CI
-5.74
-0.87).Digital
reduces
symptoms,
promotes
prevention.
For
nonsuicidal
patients,
serve
as
highly
accessible
monotherapy
improving
sleep,
thereby
reducing
risk
be
appropriately
administered
an
adjunct
support
mainline
intervention
more
targeting
suicidogenic
thoughts.
npj Digital Medicine,
Journal Year:
2023,
Volume and Issue:
6(1)
Published: March 25, 2023
Abstract
Despite
research
into
the
development
of
digital
cognitive
behavioral
therapy
for
insomnia
(dCBT-I),
outcomes
dCBT-I
on
and
associated
clinical
conditions
depression
anxiety
have
been
limited.
The
PubMed,
PsycINFO
(Ovid),
Embase,
Cochrane
databases
were
searched
randomized
controlled
trials
(RCTs)
adult
patients
with
also
having
reported
measures
depressive
or
symptoms.
In
total,
2504
articles
identified
after
duplicate
removal,
22
RCTs
included
in
final
meta-analysis.
At
post-treatment
assessment,
group
had
a
small
to
moderate
effect
alleviating
(standardized
mean
difference
(SMD)
=
−0.42;
95%
CI:
−0.56,
−0.28;
p
<
0.001;
k
21)
symptoms
(SMD
−0.29;
−0.40,
−0.19;
18),
but
large
sleep
outcome
−0.76;
−0.95,
−0.57;
22).
When
considering
treatment
adherence,
effects
those
high
adherent
groups
more
robust
outcome,
showing
greater
sizes
than
low
depression,
anxiety,
outcomes.
Furthermore,
additional
subgroup
analysis
studies
that
used
fully
automated
without
support
human
therapists
significant
results
demonstrated
intervention
yielded
as
well
Specifically,
study
above
when
adherence
implementing
dCBT-I.
JMIR Mental Health,
Journal Year:
2023,
Volume and Issue:
10, P. e47433 - e47433
Published: July 6, 2023
Evidence
suggests
that
digital
mental
health
interventions
(DMHIs)
for
common
conditions
are
effective.
However,
interventions,
such
as
face-to-face
therapies,
pose
risks
to
patients.
A
safe
intervention
is
considered
one
in
which
the
measured
benefits
outweigh
identified
and
mitigated
risks.
BMC Psychiatry,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: April 28, 2023
Abstract
Background
Pregnancy
and
the
postpartum
period
are
times
when
women
at
increased
risk
for
depression
mental
problems.
This
may
also
negatively
affect
foetus.
Thus,
there
is
a
need
interventions
with
low-threshold
access
care.
Telemedicine
promising
approach
to
address
these
issues.
systematic
literature
review
examined
efficacy
of
telemedicine
pregnant
and/or
new
mothers
health-related
outcomes.
The
primary
objective
was
analyse
whether
can
reduce
health
problems
in
mothers.
secondary
aim
clarify
impact
type
interventions,
their
frequency
targets.
Methods
Inclusion
criteria:
randomized
controlled
trials,
participants
being
(with
infants
up
twelve
months),
involving
any
kind
(e.g.
websites,
apps,
chats,
telephone),
addressing
outcomes
like
depression,
postnatal
anxiety,
stress
others.
Search
terms
were
women,
mothers,
telemedicine,
RCT
(randomised
trials),
as
well
numerous
synonyms
including
medical
subject
headings.
search
conducted
within
databases
PubMed,
Cochrane
Library,
Web
Science
PsycINFO.
Screening,
inclusion
records
data
extraction
performed
by
two
researchers
according
PRISMA
guidelines,
using
online
tool
CADIMA.
Results
Forty
four
articles
included.
A
majority
(62%)
reported
significantly
improved
receiving
compared
control.
In
particular
(internet-delivered)
Cognitive
Behavioural
Therapy
successful
stress,
peer
support
anxiety.
Interventions
preventive
approaches
aimed
symptom
reduction
largely
successful.
For
most
part
no
significant
improvement
symptoms
Conclusion
evaluated
RCTs
mostly
However,
they
be
designed
specifically
target
certain
issue
because
one-size-fits-all
approach.
Further
research
should
focus
on
which
specific
appropriate
intervention
delivery
modes,
content,
approaches,
etc.
investigation
needed,
regard
npj Digital Medicine,
Journal Year:
2025,
Volume and Issue:
8(1)
Published: March 12, 2025
Insomnia
impairs
daily
functioning
and
increases
health
risks.
Cognitive
behavioral
therapy
for
insomnia
(CBT-I)
is
effective
but
limited
by
cost
therapist
availability.
Fully
automated
digital
CBT-I
(FA
dCBT-I)
provides
an
accessible
alternative
without
involvement.
This
systematic
review
meta-analysis
evaluated
the
effectiveness
of
FA
dCBT-I
across
29
randomized
controlled
trials
(RCTs)
involving
9475
participants.
Compared
to
control
groups,
demonstrated
moderate
large
effects
on
severity.
Subgroup
analyses
indicated
that
had
a
significant
impact
when
contrasted
with
most
groups
was
less
than
therapist-assisted
CBT-I.
Meta-regression
revealed
group
type
moderated
outcomes,
whereas
completion
rate
did
not.
implies
treatment
adherence,
rather
merely
completing
intervention,
crucial
its
effectiveness.
study
supports
potential
as
promising
option
managing
underscores
hybrid
model
combining
support
more
beneficial.
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(7), P. 2265 - 2265
Published: March 26, 2025
Background/Objectives:
This
systematic
review
explores
the
integration
of
digital
and
AI-enhanced
cognitive
behavioral
therapy
(CBT)
for
insomnia,
focusing
on
underlying
neurocognitive
mechanisms
associated
clinical
outcomes.
Insomnia
significantly
impairs
functioning,
overall
health,
quality
life.
Although
traditional
CBT
has
demonstrated
efficacy,
its
scalability
ability
to
deliver
individualized
care
remain
limited.
Emerging
AI-driven
interventions-including
chatbots,
mobile
applications,
web-based
platforms-present
innovative
avenues
delivering
more
accessible
personalized
insomnia
treatments.
Methods:
Following
PRISMA
guidelines,
this
synthesized
findings
from
78
studies
published
between
2004
2024.
A
search
was
conducted
across
PubMed,
Scopus,
Web
Science,
PsycINFO.
Studies
were
included
based
predefined
criteria
prioritizing
randomized
controlled
trials
(RCTs)
high-quality
empirical
research
that
evaluated
AI-augmented
interventions
targeting
sleep
disorders,
particularly
insomnia.
Results:
The
suggest
improves
parameters,
patient
adherence,
satisfaction,
personalization
in
alignment
with
individual
profiles.
Moreover,
these
technologies
address
critical
limitations
conventional
CBT,
notably
those
related
access
scalability.
AI-based
tools
appear
especially
promising
optimizing
treatment
delivery
adapting
cognitive-behavioral
patterns.
Conclusions:
While
demonstrates
strong
potential
advancing
through
broader
accessibility,
several
challenges
persist.
These
include
uncertainties
surrounding
long-term
practical
implementation
barriers,
ethical
considerations.
Future
large-scale
longitudinal
is
necessary
confirm
sustained
benefits
AI-powered
Neuropsychiatric Disease and Treatment,
Journal Year:
2021,
Volume and Issue:
Volume 17, P. 2549 - 2566
Published: Aug. 1, 2021
Abstract:
Chronic
insomnia
disorder,
which
affects
6–
10%
of
the
population,
is
diagnostically
characterized
by
ongoing
difficulties
with
initiating
or
maintaining
sleep
occurring
at
least
three
times
per
week,
persisting
for
3
months,
and
associated
daytime
impairment.
While
chronic
often
considered
a
condition
primarily
related
to
impaired
sleep,
disorder
can
also
adversely
affect
domains
physical
mental
health,
quality
life,
function,
highlights
importance
treating
multidimensional
disorder.
Owing
misperceptions
about
safety
effectiveness
treatment
options,
many
individuals
may
not
seek
professional
treatment,
alternatively
use
ineffective
home
remedies
over-the-counter
medications
improve
sleep.
Some
physicians
even
believe
that
remediated
simply
having
patient
"get
more
sleep".
Unfortunately,
always
simple.
The
disorder's
complex
underlying
pathophysiology
warrants
consideration
different
nonpharmacologic
pharmacologic
options.
Indeed,
recent
insights
gained
from
research
into
have
facilitated
development
newer
approaches
efficacious
outcomes.
This
narrative
review
provides
summary
diagnostic
criteria
its
subtypes.
Further,
this
emphasizes
new
emerging
treatments
insomnia,
including
enhancements
in
cognitive
behavioral
therapy
(CBT-I)
dual
orexin
receptor
antagonist
(DORA)
pharmacologics.
These
advances
expanded
options
are
likely
result
improved
outcomes
patients
insomnia.
Keywords:
antagonists,
therapy-insomnia,
subtype,
hypnotic
Obstetrics and Gynecology,
Journal Year:
2022,
Volume and Issue:
unknown
Published: July 7, 2022
Compared
with
men,
women
have
a
greater
risk
of
sleep
disorders
and
report
higher
rates
disturbance.
Hormonal
physiologic
changes
throughout
the
life
span
appear
to
influence
woman's
ability
get
good
night's
sleep.
Sleep
disturbances
are
commonly
reported
during
pregnancy,
affecting
more
than
one-half
all
pregnancies
increasing
as
gestation
progresses.
The
pervasiveness
complaints
pregnancy
may
lead
belief
that
these
symptoms
normal
or
be
expected.
Unfortunately,
this
perception
impede
accurate
diagnosis
crucial
time.
Obstructive
apnea,
insomnia,
restless
legs
syndrome
most
common
in
pregnancy.
disruption
can
substantially
worsen
maternal
quality
factor
for
adverse
outcomes.
This
review
outlines
important
considerations
obstetricians
taking
care
pregnant
patients
sleep-related
complaints.